Mack-Brooks Exhibitions has announced the postponement of the fine and speciality chemicals trade show, Chemspec Europe 2021 in view of continued uncertainties regarding travel restrictions and event planning during the COVID-19 pandemic.
Hamburg-based chemical distributor Krahn Chemie has bought majority stakes in six companies from Jollis & Partners of Sweden. This follows the acquisition of InterActive in Greece in 2020.
Carolyn Buller of Squire Patton Boggs takes a look back at a year like no other in chemicals
In a letter to government ministers that has been seen by the Financial Times, 25 industry leaders have called for “a more proportionate, effective and efficient” post-Brexit chemical regulatory regime in the UK.
Following a long period of speculation, Lonza has entered into a definitive agreement to sell its Lonza Specialty Ingredients (LSI) business to private equity firms Bain Capital and Cinven for CHF 4.2 billion in order to focus entirely on healthcare.
Lanxess has signed a binding agreement to acquire Emerald Kalama Chemical from private equity firm American Securities for €867 million.
Sumitomo Chemical is to install new lines to expand production capacity for photoresists for advanced semiconductor photolithography processes, including argon fluoride (ArF) immersion and extreme ultraviolet (EUV) lithography, at its Osaka Works.
Chemours has divided its former Fluoroproducts segment into two new reportable segments under newly appointed presidents.
UK-based CDMO Arcinova has been acquired by Quotient Sciences, a ‘drug development and manufacturing accelerator’ that is itself owned by private equity firm Permira. BGF, which had part-owned Arcinova since 2018, will withdraw from its minority stake. Terms were not disclosed.
Current Issue
Mack-Brooks Exhibitions has announced the postponement of the fine and speciality chemicals trade show, Che
Hamburg-based chemical distributor Krahn Chemie has bought majority stakes in six companies from Jollis &am
Carolyn Buller of Squire Patton Boggs takes a look back at a year like no other in chemicals
In a letter to government ministers that has been seen by the Financial Times, 25 industry leaders
Most Popular
Roger-Marc Nicoud, CEO of Ypso-Facto, looks at the challenges and opportunities for CDMOs in the current crisis*
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general.